Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 31.12%248.66M | -47.95%117.1M | -47.95%117.1M | -20.38%175.57M | 4.96%113.76M | -37.09%189.65M | 117.18%224.97M | 117.18%224.97M | -45.87%220.5M | -89.10%108.38M |
-Cash and cash equivalents | 31.12%248.66M | -47.95%117.1M | -47.95%117.1M | -20.38%175.57M | 4.96%113.76M | -37.09%189.65M | 117.18%224.97M | 117.18%224.97M | -45.87%220.5M | -89.10%108.38M |
Receivables | -1.24%19.65M | -0.18%19.48M | -0.18%19.48M | 6.96%20.1M | 4.67%19.86M | 7.28%19.9M | 5.24%19.52M | 5.24%19.52M | 5.51%18.79M | 19.24%18.97M |
-Accounts receivable | -1.24%19.65M | -0.18%19.48M | -0.18%19.48M | 6.96%20.1M | 4.67%19.86M | 7.28%19.9M | 5.24%19.52M | 5.24%19.52M | 5.51%18.79M | 19.24%18.97M |
Net loan | 7.63%4.71B | 10.78%4.75B | 10.78%4.75B | 9.67%4.63B | 6.56%4.48B | 7.24%4.38B | 6.98%4.29B | 6.98%4.29B | 6.59%4.22B | 9.65%4.21B |
-Gross loan | 7.60%4.76B | 10.76%4.8B | 10.76%4.8B | 9.66%4.68B | 6.60%4.53B | 7.29%4.43B | 7.03%4.34B | 7.03%4.34B | 6.64%4.27B | 9.72%4.25B |
-Allowance for loans and lease losses | 4.87%52.16M | 9.31%52.47M | 9.31%52.47M | 9.47%51.39M | 10.37%51.22M | 11.84%49.74M | 11.66%48M | 11.66%48M | 11.54%46.95M | 16.91%46.41M |
Securities and investments | -18.30%1.41B | -21.67%1.47B | -21.67%1.47B | -17.01%1.57B | -18.33%1.66B | -16.73%1.73B | -10.68%1.87B | -10.68%1.87B | -11.04%1.89B | 12.62%2.03B |
-Available for sale securities | --73.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Held to maturity securities | -4.97%697.56M | -4.89%703.29M | -4.89%703.29M | -3.67%719.4M | -3.57%727.34M | -3.44%734.01M | -3.52%739.44M | -3.52%739.44M | -3.42%746.85M | 22.52%754.28M |
-Short term investments | -35.49%642.85M | -32.61%764.39M | -32.61%764.39M | -25.69%852.78M | -27.05%931.25M | -24.40%996.51M | -14.80%1.13B | -14.80%1.13B | -15.38%1.15B | 7.49%1.28B |
Federal home loan bank stock | 275.55%16.16M | 414.52%21.54M | 414.52%21.54M | 102.95%16.99M | 166.37%22.3M | -81.84%4.3M | -53.05%4.19M | -53.05%4.19M | -6.09%8.37M | -6.09%8.37M |
Bank owned life insurance | -10.32%112.66M | -11.11%111.7M | -11.11%111.7M | 2.92%127.25M | 2.86%126.42M | 2.32%125.62M | 2.95%125.66M | 2.95%125.66M | 1.87%123.64M | 1.87%122.91M |
Net PPE | -4.07%71.08M | -4.43%71.58M | -4.43%71.58M | -5.15%72.5M | -7.79%73.22M | -7.49%74.09M | -2.64%74.9M | -2.64%74.9M | -0.32%76.44M | 2.90%79.4M |
-Gross PPE | ---- | 1.02%112.16M | 1.02%112.16M | ---- | ---- | ---- | 0.72%111.03M | 0.72%111.03M | ---- | ---- |
-Accumulated depreciation | ---- | -12.32%-40.58M | -12.32%-40.58M | ---- | ---- | ---- | -8.47%-36.13M | -8.47%-36.13M | ---- | ---- |
Goodwill and other intangible assets | -0.62%243.79M | -0.67%244.09M | -0.67%244.09M | -0.74%244.49M | -0.82%244.89M | -0.90%245.31M | -0.98%245.73M | -0.98%245.73M | -1.01%246.33M | -1.04%246.92M |
-Goodwill | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M | 0.00%240.94M |
-Other intangible assets | -34.81%2.85M | -34.22%3.15M | -34.22%3.15M | -34.05%3.55M | -33.94%3.95M | -33.80%4.37M | -33.68%4.79M | -33.68%4.79M | -31.81%5.39M | -30.20%5.98M |
Other assets | -9.95%291.28M | -4.75%303.45M | -4.75%303.45M | -13.38%296.19M | 8.67%319.43M | 14.94%323.47M | 7.56%318.57M | 7.56%318.57M | 48.22%341.95M | 39.08%293.95M |
Total assets | 0.54%7.13B | -0.96%7.11B | -0.96%7.11B | 0.04%7.15B | -0.78%7.06B | -2.01%7.09B | 2.79%7.17B | 2.79%7.17B | -0.69%7.15B | -2.75%7.12B |
Liabilities | ||||||||||
Total deposits | 5.66%5.85B | 1.51%5.68B | 1.51%5.68B | 1.30%5.71B | -1.43%5.52B | -4.43%5.53B | -5.48%5.6B | -5.48%5.6B | -9.66%5.64B | -11.61%5.6B |
Federal funds purchased and securities sold under agreement to repurchase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -42.75%23.16M | -8.64%38.22M |
Long term debt and capital lease obligation | -45.09%286.53M | -22.37%405.06M | -22.37%405.06M | -14.35%403.99M | 10.66%521.91M | 28.96%521.84M | 2,329.87%521.77M | 2,329.87%521.77M | 2,104.27%471.69M | 2,111.47%471.62M |
-Long term debt | -45.09%286.53M | -22.37%405.06M | -22.37%405.06M | -14.35%403.99M | 10.66%521.91M | 28.96%521.84M | 2,329.87%521.77M | 2,329.87%521.77M | 2,104.27%471.69M | 2,111.47%471.62M |
Other liabilities | -38.54%116.48M | -23.48%153.08M | -23.48%153.08M | -19.63%166.37M | -9.73%171.79M | 6.54%189.54M | 5.69%200.06M | 5.69%200.06M | 66.90%207.01M | 61.60%190.3M |
Total liabilities | 0.07%6.25B | -1.25%6.24B | -1.25%6.24B | -0.92%6.28B | -1.37%6.21B | -2.61%6.24B | 2.26%6.32B | 2.26%6.32B | -1.35%6.34B | -3.31%6.3B |
Shareholders'equity | ||||||||||
Share capital | -2.30%532.12M | -3.29%531.67M | -3.29%531.67M | -2.50%534.92M | -1.60%541.29M | -1.13%544.64M | -0.48%549.75M | -0.48%549.75M | -0.50%548.65M | -0.06%550.1M |
-common stock | -2.30%532.12M | -3.29%531.67M | -3.29%531.67M | -2.50%534.92M | -1.60%541.29M | -1.13%544.64M | -0.48%549.75M | -0.48%549.75M | -0.50%548.65M | -0.06%550.1M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 5.11%392.74M | 2.95%387.1M | 2.95%387.1M | 1.48%383.13M | 3.44%379.71M | 4.36%373.63M | 8.87%375.99M | 8.87%375.99M | 14.30%377.52M | 15.90%367.09M |
Gains losses not affecting retained earnings | 38.68%-43.35M | 23.78%-55.24M | 23.78%-55.24M | 61.35%-43.53M | 27.66%-70.5M | 14.63%-70.69M | 27.42%-72.48M | 27.42%-72.48M | -7.26%-112.63M | -57.74%-97.46M |
Total stockholders'equity | 4.00%881.52M | 1.20%863.53M | 1.20%863.53M | 7.49%874.51M | 3.75%850.51M | 2.60%847.58M | 6.94%853.26M | 6.94%853.26M | 4.74%813.55M | 1.78%819.73M |
Total equity | 4.00%881.52M | 1.20%863.53M | 1.20%863.53M | 7.49%874.51M | 3.75%850.51M | 2.60%847.58M | 6.94%853.26M | 6.94%853.26M | 4.74%813.55M | 1.78%819.73M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |